Zydus Group firm Cadila Healthcare’s subsidiary Nesher Pharmaceuticals has received nod from the USFDA to market Nystatin topical powder used for treating skin infections in the US market. The drug will be produced at Nesher Pharmaceuticals manufacturing facility in USA, the company said in a BSE filing.
Fitness start-ups see spike in growth as urban health awareness improves
Amtek reports loss of Rs 2,533 crore in FY17
Zydus' Nesher Pharma gets US FDA nod for antifungal drug
The drug will be produced at Nesher Pharmaceuticals manufacturing facility in USA
Press Trust of India |
Zydus
First Published: Sat, June 10 2017. 22:16 IST
Advertisements
RECOMMENDED FOR YOU